A
Active Biotech AB publ
STO:ACTI
Active Biotech AB publ
STO:ACTI
Price:
0.0681
SEK
-1.3%
Market Cap:
kr179.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Depreciation & Amortization
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Active Biotech AB publ
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Depreciation & Amortization
kr1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Depreciation & Amortization
kr24.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Depreciation & Amortization
kr7.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Depreciation & Amortization
kr427m
|
CAGR 3-Years
3%
|
CAGR 5-Years
38%
|
CAGR 10-Years
23%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Depreciation & Amortization
kr10.1B
|
CAGR 3-Years
61%
|
CAGR 5-Years
38%
|
CAGR 10-Years
41%
|
|
|
BioArctic AB
STO:BIOA B
|
Depreciation & Amortization
kr12.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
ACTI
Intrinsic Value
0.029
SEK
Overvaluation 57%
A
See Also
What is Active Biotech AB publ's Depreciation & Amortization?
Depreciation & Amortization
1.6m
SEK
1.6m
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Depreciation & Amortization amounts to 1.6m SEK.
What is Active Biotech AB publ's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 1Y
-3%
-3%
Over the last year, the Depreciation & Amortization growth was -3%.
